arrow
M

Mirian Brink

iknl
H指数:16
被引数:1,503

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multiple myeloma in the Netherlands: 35-year trends in incidence and survival

荷兰多发性骨髓瘤:35年发病率和生存趋势

Leukemia
IF13.4
2026-10-220
OAAI
Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies
2024-12-010
PRE
Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands
2023-10-051
OAAI
Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysis
2022-11-013
OAAI
Increased mortality risk in multiple-myeloma patients with subsequent malignancies: a population-based study in the Netherlands

多发性骨髓瘤继发恶性肿瘤患者的死亡风险增加: 荷兰一项基于人群的研究

2022-03-157
OAAI
Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands: a population-based study

荷兰初诊多发性骨髓瘤患者早期死亡率降低: 一项基于人群的研究

2021-11-116
OAAI
Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based study
2021-08-0214
OA